Globe Life Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $6.2B+7.2% YoYTTM through 30 Jun 2026
Net Income $1.2B+13.2% YoYTTM through 30 Jun 2026
Free Cash Flow $1.2BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | 20.0% |
| Net Margin | 19.6% |
Returns
20.9%ROE
3.8%ROA
13.7%ROIC
Balance Sheet Health
Debt / Equity0.44x
Net Debt$2.5B
Cash & Equivalents$257.1M
Quality Metrics
Piotroski F-Score6 / 9
FCF Margin19.9%
Rule of 4023.3
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $6B
Diluted EPS$15.04TTMFY2025: $14.07
Dividend
$0.93Per share, FY20260.55%Yield+3.5%5-yr growth
Capital Allocation
Capex Intensity2.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Life Insurance | $3.4B | +3.0% | View detailsSteady growth driven by exclusive agency distribution and favorable mortality experience. |
| Health Insurance | $1.5B | +9.0% | View detailsGrowth supported by rate increases in Medicare supplement business and expanding sales. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.